Clinical Trials Browser

Phase 2 × Breast Neoplasms × futibatinib × Clear all

NCT04024436 2025-11-13

A Study of TAS-120 in Patients With Metastatic Breast Cancer

Phase 2 Terminated

64 enrolled 21 charts

Breast Neoplasms